BMRA vs. SDC, ICCC, AWH, OCX, CDIO, MYMD, VRAX, NAVB, NVST, and XRAY
Should you be buying Biomerica stock or one of its competitors? The main competitors of Biomerica include SmileDirectClub (SDC), ImmuCell (ICCC), Aspira Women's Health (AWH), OncoCyte (OCX), Cardio Diagnostics (CDIO), MyMD Pharmaceuticals (MYMD), Virax Biolabs Group (VRAX), Navidea Biopharmaceuticals (NAVB), Envista (NVST), and DENTSPLY SIRONA (XRAY). These companies are all part of the "medical" sector.
SmileDirectClub (NASDAQ:SDC) and Biomerica (NASDAQ:BMRA) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, valuation, profitability, earnings, analyst recommendations, media sentiment, institutional ownership, dividends and community ranking.
Biomerica has lower revenue, but higher earnings than SmileDirectClub. Biomerica is trading at a lower price-to-earnings ratio than SmileDirectClub, indicating that it is currently the more affordable of the two stocks.
In the previous week, Biomerica had 1 more articles in the media than SmileDirectClub. MarketBeat recorded 2 mentions for Biomerica and 1 mentions for SmileDirectClub. SmileDirectClub's average media sentiment score of 0.92 beat Biomerica's score of 0.00 indicating that Biomerica is being referred to more favorably in the news media.
SmileDirectClub has a beta of 2.42, suggesting that its share price is 142% more volatile than the S&P 500. Comparatively, Biomerica has a beta of -0.92, suggesting that its share price is 192% less volatile than the S&P 500.
Biomerica received 33 more outperform votes than SmileDirectClub when rated by MarketBeat users. Likewise, 67.82% of users gave Biomerica an outperform vote while only 61.54% of users gave SmileDirectClub an outperform vote.
SmileDirectClub has a net margin of -19.94% compared to SmileDirectClub's net margin of -117.46%. Biomerica's return on equity of 0.00% beat SmileDirectClub's return on equity.
4.3% of SmileDirectClub shares are owned by institutional investors. Comparatively, 22.3% of Biomerica shares are owned by institutional investors. 64.7% of SmileDirectClub shares are owned by insiders. Comparatively, 13.5% of Biomerica shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
Summary
SmileDirectClub and Biomerica tied by winning 7 of the 14 factors compared between the two stocks.
Get Biomerica News Delivered to You Automatically
Sign up to receive the latest news and ratings for BMRA and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding BMRA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Biomerica Competitors List
Related Companies and Tools
